Jan Grimm
Member/Professor · New York Presbyterian Hospital
Credentials: · · · · ·
History
- 2000–2003
- 1995–1996
Preliminary or Transitional Year
- 1991–1995
University of Hamburg Germany
Research
Restoration of p53 function leads to tumour regression in vivo
Nature · 2007 · 1,534 citations
Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta
Science · 1998 · 1,107 citations
An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles
Nature Materials · 2006 · 544 citations
- RW
15 papers
- MK
9 papers
5 papers · 2 as a resident
- CR
3 papers
3 papers
- WW
3 papers
- DS
2 papers
- HH
2 papers
Grants
- 2026–2031
Modulating the Tumor Microenvironment to Enhance Nanoparticle Delivery
National Cancer Institute · R01
Contact PI · $699.8K · Sloan-Kettering Inst Can Research
- 2026–2031
National Cancer Institute · R01
Contact PI · $644.4K · Sloan-Kettering Inst Can Research
- 2021–2027
PSMA’s Enzymatic Activity as New Target for Prostate Cancer Diagnosis and Therapy
National Cancer Institute · R01
Contact PI · $3.6M · Sloan-Kettering Inst Can Research
- 2023–2027
Multicolor PET to Interrogate Cancer Biology
National Institute of Biomedical Imaging and Bioengineering · R01
Contact PI · $2.6M · Sloan-Kettering Inst Can Research
Clinical trials
- 2022–2026
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
- 2018–2027
A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
- 2012–2018
Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center